"
Team:Bonn/Project
From 2012.igem.org
(→LOV Kills) |
(→LOV-Blues) |
||
| Line 31: | Line 31: | ||
= Project Details = | = Project Details = | ||
| - | === LOV-Blues === | + | === LOV-Blues / Lov-LacZalpha === |
In our proof-of-principle, we are coupling LacZalpha to the LOV domain. LacZalpha is one of two parts of a split-version beta-galactosidase, which upon exposure to light will resume galactosidase activity in mutants containing LacZomega, the complimentary second part of beta-galactosidase. Using a chromophore substrate for our beta-galactosidase gives us a simple blue-to-white assay. | In our proof-of-principle, we are coupling LacZalpha to the LOV domain. LacZalpha is one of two parts of a split-version beta-galactosidase, which upon exposure to light will resume galactosidase activity in mutants containing LacZomega, the complimentary second part of beta-galactosidase. Using a chromophore substrate for our beta-galactosidase gives us a simple blue-to-white assay. | ||
Revision as of 21:20, 26 September 2012
| Home | Team | Project | Activities | Parts Submitted to the Registry | Notebook | Safety | Attributions | Sponsors |
|---|
|
Contents |
Overall project
Control of protein activity at the peptide level offers spatial-temporal control and quick reaction times, but so far has always involved target-specific tools, such as specific chemical inhibitors or proteases. We are developing and characterizing a fusion construct containing a light sensitive domain that provides quick, universal peptide-level light control of proteins of interest within the framework of easy biobrick-conform coupling.
We are engineering the LOV (Light, Oxygen, Voltage) domain – commonly found in plants where it enables light-directed growth – to control protein activity through blue light. Upon exposure, the LOV domain undergoes a conformational change and shifts away from the protein of interest, uncaging the coupled protein and allowing it to resume activity. In our project, we coupled a small part of the beta-galactosidase (which offers a simple assay) to the LOV domain as a proof-of-principle. We also built a cell death device using ccdB, a gyrase inhibitor. Furthermore we will design a MazF construct, as an example for a Hydrolase.
Potential applications of our LOV fusion system include bioreactor regulation or site-specific drug activation.
Project Details
LOV-Blues / Lov-LacZalpha
In our proof-of-principle, we are coupling LacZalpha to the LOV domain. LacZalpha is one of two parts of a split-version beta-galactosidase, which upon exposure to light will resume galactosidase activity in mutants containing LacZomega, the complimentary second part of beta-galactosidase. Using a chromophore substrate for our beta-galactosidase gives us a simple blue-to-white assay.
LOV Kills / LOV-Ccdb
To show one of the many, wide-ranging possible applications, we will fuse a cell death protein, ccdB, to our LOV construct. Upon light exposure, the cell will go into apoptosis.
LOV Cuts / LOV-MazF
MazF is a ACA-specific ribonuclease from B. subtilis which in nature is used for toxin/antitoxin addiction systems. It leads to programmed cell death in bacteria upon high-scale expression, thus qualifying it for use in cell death devices.
Fusion System
Our Approach
For detailed information about the experiments we did in the lab visit our Notebook.
